BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 9424569)

  • 1. Meta-analyses and large randomized, controlled trials.
    Stewart LA; Parmar MK; Tierney JF
    N Engl J Med; 1998 Jan; 338(1):61; author reply 61-2. PubMed ID: 9424569
    [No Abstract]   [Full Text] [Related]  

  • 2. Meta-analyses and large randomized, controlled trials.
    Ioannidis JP; Cappelleri JC; Lau J
    N Engl J Med; 1998 Jan; 338(1):59; author reply 61-2. PubMed ID: 9424563
    [No Abstract]   [Full Text] [Related]  

  • 3. Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.
    Shrier I; Boivin JF; Steele RJ; Platt RW; Furlan A; Kakuma R; Brophy J; Rossignol M
    Am J Epidemiol; 2007 Nov; 166(10):1203-9. PubMed ID: 17712019
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Should meta-analyses of interventions include observational studies in addition to randomized controlled trials? A critical examination of underlying principles.
    Pereira C; Castilho E
    Am J Epidemiol; 2009 Mar; 169(6):783; author reply 783-4. PubMed ID: 19208724
    [No Abstract]   [Full Text] [Related]  

  • 5. Robustness assessments are needed to reduce bias in meta-analyses that include zero-event randomized trials.
    Keus F; Wetterslev J; Gluud C; Gooszen HG; van Laarhoven CJ
    Am J Gastroenterol; 2009 Mar; 104(3):546-51. PubMed ID: 19262513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can quality of clinical trials and meta-analyses be quantified?
    Ioannidis JP; Lau J
    Lancet; 1998 Aug; 352(9128):590-1. PubMed ID: 9746014
    [No Abstract]   [Full Text] [Related]  

  • 7. Investigating patient exclusion bias in meta-analysis.
    Tierney JF; Stewart LA
    Int J Epidemiol; 2005 Feb; 34(1):79-87. PubMed ID: 15561753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between unreported outcomes and effect size estimates in Cochrane meta-analyses.
    Furukawa TA; Watanabe N; Omori IM; Montori VM; Guyatt GH
    JAMA; 2007 Feb; 297(5):468-70. PubMed ID: 17284696
    [No Abstract]   [Full Text] [Related]  

  • 9. Meta-analysis and meta-analytic monitoring of clinical trials.
    Feinstein AR
    Stat Med; 1996 Jun; 15(12):1273-80; discussion 1281-3. PubMed ID: 8817801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danger of misuse of meta-analyses for observational studies based on published data.
    Sauerbrei W; Blettner M
    Stud Health Technol Inform; 2000; 77():33. PubMed ID: 11187567
    [No Abstract]   [Full Text] [Related]  

  • 11. PEDro's bias: summary quality scores should not be used in meta-analysis.
    da Costa BR; Hilfiker R; Egger M
    J Clin Epidemiol; 2013 Jan; 66(1):75-7. PubMed ID: 23177896
    [No Abstract]   [Full Text] [Related]  

  • 12. The promise and problems of meta-analysis.
    Bailar JC
    N Engl J Med; 1997 Aug; 337(8):559-61. PubMed ID: 9262502
    [No Abstract]   [Full Text] [Related]  

  • 13. [A wide perspective on meta-analysis--may be of crucial significance for the patients].
    Gøtzsche PC
    Tidsskr Nor Laegeforen; 2000 Sep; 120(23):2810. PubMed ID: 11107932
    [No Abstract]   [Full Text] [Related]  

  • 14. A methodological review of recent meta-analyses has found significant heterogeneity in age between randomized groups.
    Clark L; Fairhurst C; Hewitt CE; Birks Y; Brabyn S; Cockayne S; Rodgers S; Hicks K; Hodgson R; Littlewood E; Torgerson DJ
    J Clin Epidemiol; 2014 Sep; 67(9):1016-24. PubMed ID: 24909873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjustment of meta-analyses on the basis of quality scores should be abandoned.
    Herbison P; Hay-Smith J; Gillespie WJ
    J Clin Epidemiol; 2006 Dec; 59(12):1249-56. PubMed ID: 17098567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Commentary: Empirical evidence of attrition bias in clinical trials.
    Jüni P; Egger M
    Int J Epidemiol; 2005 Feb; 34(1):87-8. PubMed ID: 15649954
    [No Abstract]   [Full Text] [Related]  

  • 17. Allocation concealment in clinical trials.
    Schulz KF; Altman DG; Moher D
    JAMA; 2002 Nov; 288(19):2406-7; author reply 2408-9. PubMed ID: 12435253
    [No Abstract]   [Full Text] [Related]  

  • 18. Different methods of allocation to groups in randomized trials are associated with different levels of bias. A meta-epidemiological study.
    Herbison P; Hay-Smith J; Gillespie WJ
    J Clin Epidemiol; 2011 Oct; 64(10):1070-5. PubMed ID: 21474279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Meta-analyses in psychopharmacotherapy: garbage in--garbage out?].
    Weinmann S
    Psychiatr Prax; 2009 Sep; 36(6):255-7. PubMed ID: 19707997
    [No Abstract]   [Full Text] [Related]  

  • 20. [Importance of a wide perspective on meta-analysis. It may be of crucial significance for the patients].
    Gøtzsche PC
    Ugeskr Laeger; 2000 Oct; 162(42):5601. PubMed ID: 11059294
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.